What is the global market size of Women’s Health Devices Market?

Global Women's Health Devices Market size was valued at USD 38.43 billion in 2021 and is poised to grow from USD 40.29 billion in 2022 to USD 468.18 billion by 2030, growing at a CAGR of 4.8% in the forecast period (2023-2030).

Women's Health Devices Market Companies

Women's Health Devices Market Competitive Landscape

Due to their product offerings focused on female urinary incontinence and diagnostics, other businesses like Coloplast A/S and Hologic Inc. also hold a significant market share of the global market. Several rising businesses are anticipated to emerge as a result of increased investment activities in the women's health devices market, and these businesses may grow their market shares during the forecast period.

Top Players in the Global Women’s Health Devices Market

CooperSurgical Inc.
GE Healthcare
Koninklijke Philips N.V.
Siemens AG
Medtronic plc
Boston Scientific Corporation
Hologic Inc.
Johnson & Johnson
Abbott Laboratories
F. Hoffmann-La Roche AG
Merck & Co., Inc.
Pfizer Inc.
Bayer AG
Becton, Dickinson and Company
Cardinal Health, Inc.
Thermo Fisher Scientific Inc.
Olympus Corporation
Fujifilm Holdings Corporation
Danaher Corporation
Smith & Nephew plc

Women's Health Devices Market Recent Development

February 2021 – CooperSurgical announced the acquisition of U.S.-based AEGEA Medical and its FDA-approved Mara Water Vapor Ablation System, which is an endometrial ablation treatment.
January 2021 – Reckitt Benckiser Group PLC announced the acquisition of Queen V, a female sexual wellness brand established in the US, focused on vaginal health.

FAQs

Global Women's Health Devices Market size was valued at USD 42.12 Billion in 2024 and is poised to grow from USD 44.15 Billion in 2025 to USD 64.24 Billion by 2033, growing at a CAGR of 4.8% during the forecast period (2026–2033).

Regarding the women's health devices market's competitive environment, there are numerous businesses of varying sizes present, each with a varied product portfolio and a broad range of potential applications. F. Hoffmann-La Roche Ltd. currently holds a dominant position in the market, mostly as a result of the company's diagnostics portfolio, which includes several products that address female health issues. Numerous female cancers, as well as pregnancy and fertility, are some of the application areas of women's health that F. Hoffmann-La Roche Ltd. handles. Boston Scientific Corporation is another significant competitor with a big array of medical devices for pelvic health. 'F. Hoffmann-La Roche Ltd. (Switzerland)', 'Boston Scientific Corporation (United States) ', 'Abbott Laboratories (United States) ', 'Koninklijke Philips N.V. (Netherlands) ', 'CooperSurgical Inc. (United States) ', 'Caldera Medical Inc. (United States) ', 'Medtronic plc (Ireland) ', 'Johnson & Johnson (United States) ', 'GE HealthCare Technologies Inc. (United States) ', 'Siemens Healthineers AG (Germany) ', 'Cardinal Health Inc. (United States) ', 'Becton, Dickinson and Company (United States) ', 'Olympus Corporation (Japan) ', 'Fujifilm Holdings Corporation (Japan) ', 'Stryker Corporation (United States) ', 'Zimmer Biomet Holdings Inc. (United States) ', 'Smith & Nephew plc (United Kingdom) ', 'Intuitive Surgical Inc. (United States) ', 'Merck & Co. (United States) ', 'Hologic, Inc. (United States)'

Due to the significant increase in the number of female patients over the past several years, there has been a significant rise in the need for medical equipment for the diagnosis and treatment of diseases affecting women's health, such as a variety of female cancers. Numerous studies have shown that during the past few decades, there has been a marked rise in the prevalence of disorders affecting women's health. Several governments have launched projects to increase knowledge of female ailments to lower the mortality rate among female patients with serious illnesses.

Numerous investment initiatives are being made, which is one of the most common trends in the women's health devices market and is expected to significantly boost market growth throughout the projected period. There are a lot of benefits of aggressive investment programs. Several of the benefits of these initiatives increase the number of more practical and cheap solutions available, which encourages the widespread use of these medical devices. Additionally, these investment opportunities are anticipated to lead to the introduction of cutting-edge products.

North America dominated the global women's health devices market, with a market value of US$ 15.40 billion in 2021 and is likely to continue to do so during the forecast period. A few of the factors that contribute to this region's dominance include the substantial healthcare spending on women's health in the area and the comparably larger demand for technologically advanced devices.

Women's Health Devices Market

Report ID: SQSG35A2019

Top Women's Health Devices Companies

Women's Health Devices Market Competitive Landscape

FAQs

Request Free Customization

Top Women's Health Devices Companies

Women's Health Devices Market Competitive Landscape

FAQs

What is the global market size of Women's Health Devices Market?

Who are the key vendors in the Women's Health Devices Market?

What is the key driver of Women's Health Devices Market?

What is the key market trend for Women's Health Devices Market?

Which region accounted for the largest share in Women's Health Devices Market?

Request Free Customization